Adagio Medical Holdings, Inc.

For the period ended Dec 31, 2025. Filed Mar 27, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 27, 2026

ADGM$1.92Day change unavailableStored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

TABLE OF CONTENTS
	Page
Statement Regarding Forward Looking Statements	3

PART I

Item 1. Business	7
Item 1A. Risk Factors	24
Item 1B. Unresolved Staff Comments	79
Item 1C. Cybersecurity	79
Item 2. Properties	80
Item 3. Legal Proceedings	80
Item 4. Mine Safety Disclosures	80

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	81
Item 6. Reserved	81
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations	82
Item 7A. Quantitative and Qualitative Disclosures About Market Risk	104
Item 8. Financial Statements and Supplementary Data	104
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	164
Item 9A. Controls and Procedures	164
Item 9B. Other Information	165
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	165

PART III

Item 10. Directors, Executive Officers and Corporate Governance	165
Item 11. Executive Compensation	165
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	165
Item 13. Certain Relationships and Related Transactions, and Director Independence	165
Item 14. Principal Accounting Fees and Services	165

PART IV

Item 15. Exhibits and Financial Statement Schedules	166

Signatures	168

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.

About this filing

Table of Contents